ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Cardiol Therapeutics Inc

Cardiol Therapeutics Inc (CRDL)

1.0574
-0.0026
( -0.25% )
更新日時: 03:53:06

Cardiol Therapeutics Inc (CRDL) インサイダー取引

-
フィルター:
日付 保有者名 取引株数 金額レンジ ($) 取引種別 価格レンジ ($) 届出終了時の株数 % 変化
2025-12-03Mr. David G. ElsleyPresident, CEO & Director350.00k0.00Derivative Acquisition Under Employee Benefit Plan1.00675.00k107.69%
2025-12-03Mr. Christopher J. WaddickCFO, Corporate Secretary & Director250.00k0.00Derivative Acquisition Under Employee Benefit Plan1.00250.00k-
2025-12-03Mr. Colin G. StottIndependent Director60.00k0.00Derivative Acquisition Under Employee Benefit Plan1.0060.00k-
2025-12-03Ms. Jennifer M. ChaoIndependent Director60.00k0.00Derivative Acquisition Under Employee Benefit Plan1.0060.00k-
2025-12-03Mr. Peter PekosIndependent Director60.00k0.00Derivative Acquisition Under Employee Benefit Plan1.0060.00k-
2025-12-03Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development250.00k0.00Derivative Acquisition Under Employee Benefit Plan1.00250.00k-
2025-12-03Ms. Teri LoxamIndependent Director60.00k0.00Derivative Acquisition Under Employee Benefit Plan1.00120.00k100.00%
2025-12-03Dr. Guillermo Torre-AmioneIndependent Chairman60.00k0.00Derivative Acquisition Under Employee Benefit Plan1.0060.00k-
2025-12-03Mr. Bernard LimCOO250.00k0.00Derivative Acquisition Under Employee Benefit Plan1.00250.00k-
2025-12-03Dr. Timothy J. GarnettIndependent Director60.00k0.00Derivative Acquisition Under Employee Benefit Plan1.00120.00k100.00%
2025-10-01Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development133.33k0.00Derivative Exercise and Retained Stock-669.95k24.85%
2025-10-17Mr. David G. ElsleyPresident, CEO & Director100.00k100.00k買い1.001.34M8.04%
2025-10-17Dr. Guillermo Torre-AmioneIndependent Chairman50.00k50.00k買い1.00309.31k19.28%
2025-09-08Ms. Teri LoxamIndependent Director13.33k0.00Derivative Exercise and Retained Stock-133.33k11.11%
2025-09-08Ms. Jennifer M. ChaoIndependent Director13.33k0.00Derivative Exercise and Retained Stock-133.33k11.11%
2025-09-08Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development70.00k0.00Derivative Exercise and Retained Stock-536.61k15.00%